Login / Signup

Response to the letter to the editor by Dr. Yasar and Babaoglu on the recent publication of Kokki et al. on the pharmacokinetics of metoprolol bioavailability in coronary artery bypass surgery patients.

Hannu KokkiJari HalonenJuha Hartikainen
Published in: European journal of clinical pharmacology (2018)
Keyphrases
  • coronary artery bypass
  • end stage renal disease
  • percutaneous coronary intervention
  • ejection fraction
  • newly diagnosed
  • minimally invasive
  • chronic kidney disease
  • coronary artery disease
  • acute coronary syndrome